Upperton Pharma Solutions Revenue and Competitors

Nottingham, Nottinghamshire

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Upperton Pharma Solutions's estimated annual revenue is currently $15.2M per year.(i)
  • Upperton Pharma Solutions's estimated revenue per employee is $155,000

Employee Data

  • Upperton Pharma Solutions has 98 Employees.(i)
  • Upperton Pharma Solutions grew their employee count by 46% last year.

Upperton Pharma Solutions's People

NameTitleEmail/Phone
1
Founder & CSOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
CEOReveal Email/Phone
4
Financial OfficerReveal Email/Phone
5
Head Business OperationsReveal Email/Phone
6
Associate Director, Manufacturing OperationsReveal Email/Phone
7
Director Pharmaceutical SciencesReveal Email/Phone
8
Director Clinical ManufacturingReveal Email/Phone
9
Director Analytical ServicesReveal Email/Phone
10
Associate Director - Project ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.2M9846%N/AN/A
Add Company

What Is Upperton Pharma Solutions?

Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing. We are able to enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular we have world leading expertise and know-how in pharmaceutical spray dryings, probably the most versatile and fastest growing technology in the industry. We have experience of working with a range of dosage forms and the expertise to develop the most challenging of molecules. Our formulation work is supported by a comprehensive range of analytical services for product testing and ICH stability studies. Upperton has an extensive, multinational client-base, ranging from virtual and small start-ups to global pharma companies. We pride ourselves on our client-focused, flexible approach and scientific excellence.

keywords:N/A

N/A

Total Funding

98

Number of Employees

$15.2M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.1M98-2%N/A
#2
$32M991%N/A
#3
$21.4M102-50%N/A
#4
$34.7M1053%N/A
#5
$7.5M10922%N/A